MEDICUS PHARMA LTD (MDCX) Forecast, Price Target & Analyst Ratings

NASDAQ:MDCX • CA58471K2020

Current stock price

0.2853 USD
+0 (+0.96%)
At close:
0.281 USD
0 (-1.51%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MEDICUS PHARMA LTD (MDCX).

Forecast Snapshot

Consensus Price Target

Price Target
$6.63
+ 2,223.87% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 28, 2026
Period
Q1 / 2026
EPS Estimate
-$0.20
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.22%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$6.63
Upside
+ 2,223.87%
From current price of $0.29 to mean target of $6.63, Based on 9 analyst forecasts
Low
$2.02
Median
$7.65
High
$9.45

Price Target Revisions

1 Month
-63.21%
3 Months
-66.95%

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for MDCX. The average price target is 6.63 USD. This implies a price increase of 2223.87% is expected in the next year compared to the current price of 0.2853.
The average price target has been revised downward by 66.95% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

MDCX Current Analyst RatingMDCX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

MDCX Historical Analyst RatingsMDCX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -13 -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
82.22%
MDCX was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about MDCX.
In the previous month the buy percentage consensus was at a similar level.
MDCX was analyzed by 9 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-20D. Boral CapitalMaintains Buy -> Buy
2026-03-19D. Boral CapitalMaintains Buy -> Buy
2026-03-09D. Boral CapitalMaintains Buy -> Buy
2025-12-15D. Boral CapitalMaintains Buy -> Buy
2025-11-17D. Boral CapitalMaintains Buy -> Buy
2025-11-13D. Boral CapitalMaintains Buy -> Buy
2025-10-29D. Boral CapitalMaintains Buy -> Buy
2025-10-22D. Boral CapitalMaintains Buy -> Buy
2025-10-14D. Boral CapitalMaintains Buy -> Buy
2025-09-29D. Boral CapitalMaintains Buy -> Buy
2025-09-02D. Boral CapitalMaintains Buy -> Buy
2025-08-22D. Boral CapitalMaintains Buy -> Buy
2025-08-13D. Boral CapitalMaintains Buy -> Buy
2025-07-09D. Boral CapitalMaintains Buy -> Buy
2025-07-01D. Boral CapitalMaintains Buy -> Buy
2025-06-23D. Boral CapitalMaintains Buy -> Buy
2025-06-09D. Boral CapitalMaintains Buy -> Buy
2025-05-29D. Boral CapitalMaintains Buy -> Buy
2025-05-22D. Boral CapitalMaintains Buy -> Buy
2025-05-12D. Boral CapitalMaintains Buy -> Buy
2025-05-08Maxim GroupMaintains Buy -> Buy
2025-04-28D. Boral CapitalMaintains Buy -> Buy
2025-04-21D. Boral CapitalMaintains Buy -> Buy
2025-04-14D. Boral CapitalInitiate Buy
2024-12-17Maxim GroupInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 28, 2026
Period
Q1 / 2026
EPS Estimate
-$0.20
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
51.43%
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
-17.65%

Next Earnings Summary

MDCX is expected to report earnings on 5/28/2026. The consensus EPS estimate for the next earnings is -0.2 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
MDCX revenue by date.MDCX revenue by date.
N/AN/AN/AN/A
278.87%		N/A
168.05%		N/A
82.57%		N/A
62.33%		N/A
29.89%
EBITDA
YoY % growth
MDCX ebitda by date.MDCX ebitda by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
MDCX ebit by date.MDCX ebit by date.
-31.1K-91.9K
-195.50%		-53.4K
41.89%		-58.6K
-9.74%		-131.4K
-124.23%		-88.1K
32.95%		-141.7K
-60.84%		-978.4K
-590.47%		-2.658M
-171.70%		-11.181M
-320.60%		-25.642M
-129.34%		N/A
7.19%		N/A
-35.38%		N/A
11.24%		N/A
288.59%		N/A
290.71%		N/A
121.50%		N/A
73.81%		N/A
31.03%
Operating Margin
MDCX operating margin by date.MDCX operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
MDCX eps by date.MDCX eps by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/A-2.01
20.05%		-2.32
-15.65%		N/A
72.30%		N/A
35.71%		N/A
51.85%		N/A
443.59%		N/A
142.54%		N/A
155.38%		N/A
74.94%		N/A
20.80%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.20
51.43%		-0.19
55.07%		-0.17
73.32%		-0.08
90.17%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-6.14M
-19.78%		-6.413M
-6.59%		-6.54M
2.52%		-6.71M
13.88%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

MDCX Yearly Revenue VS EstimatesMDCX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
MDCX Yearly EPS VS EstimatesMDCX Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4 6 8

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
24.17%
EPS Next 5 Year
22.11%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

MEDICUS PHARMA LTD / MDCX Forecast FAQ

What do analysts expect the price target to be for MEDICUS PHARMA LTD (MDCX)?

9 analysts have analysed MDCX and the average price target is 6.63 USD. This implies a price increase of 2223.87% is expected in the next year compared to the current price of 0.2853.

What is the next earnings date for MDCX stock?

MEDICUS PHARMA LTD (MDCX) will report earnings on 2026-05-28.

What are the consensus estimates for MEDICUS PHARMA LTD (MDCX) next earnings?

The consensus EPS estimate for the next earnings of MEDICUS PHARMA LTD (MDCX) is -0.2 USD and the consensus revenue estimate is 0 USD.

What is the number of analysts for MDCX stock?

The number of analysts covering MEDICUS PHARMA LTD (MDCX) is 9.